Hyderabad-based Vivimed Labs Limited has acquired Kolkata-headquartered Klar Sehen Private Limited (KSPL), a 30-year-old pharmaceutical company, for an undisclosed amount.
KSPL owns about 50 trademarks and operates in the ophthalmic segment with clienteles including Renicol, Lysicon-V, Care Tears and Dexacort. It has a strong marketing presence in Northeast, Bihar and Andhra Pradesh, and has 150 medical sales professionals. It has cGMP-compliant manufacturing facilities at Kolkata and Hyderabad, and also has arrangements to manufacture some of its products in Uttarakhand.
Vivimed’s acquisition of KSPL complements its strategy to increase its domestic presence in specialty pharmaceutical areas, its knowledge and experience in manufacturing. Research and development will help grow this business to new levels, a company release said.